StockData
LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc. (LFST) stock

LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30243% above fair value
$13.77−0.40 (-2.82%)

Close on Nov 18, 2026Market cap $5.26BP/E 105.9Yield –

LifeStance Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

LifeStance Health's free cash flow for the twelve months ending Jun 30, 2026 was $173.91M, up 44.8% year over year. For fiscal 2025 it was $110.03M, up 28.4% from the year before. The highest annual figure on record is $110.03M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$110.03M+28.4%
FY2024Dec 31, 2024$85.69M–
FY2023Dec 31, 2023-$57.40M–
FY2022Dec 31, 2022-$26.47M–
FY2021Dec 31, 2021-$85.07M-3211.6%
FY2019Dec 31, 2019$2.73M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$87.92M+55.2%
Q1 FY2026Mar 31, 2026$22.34M–
Q4 FY2025Dec 31, 2025$46.65M-16.7%
Q3 FY2025Sep 30, 2025$17.00M-3.8%
Q2 FY2025Jun 30, 2025$56.64M+45.4%
Q1 FY2025Mar 31, 2025-$10.26M–
Q4 FY2024Dec 31, 2024$56.02M+941.0%
Q3 FY2024Sep 30, 2024$17.67M–
Q2 FY2024Jun 30, 2024$38.95M–
Q1 FY2024Mar 31, 2024-$26.94M–
Q4 FY2023Dec 31, 2023$5.38M-78.9%
Q3 FY2023Sep 30, 2023-$35.15M–
Q2 FY2023Jun 30, 2023-$12.02M–
Q1 FY2023Mar 31, 2023-$15.62M–
Q4 FY2022Dec 31, 2022$25.53M–
Q3 FY2022Sep 30, 2022-$9.37M–
Q2 FY2022Jun 30, 2022-$18.03M–
Q1 FY2022Mar 31, 2022-$24.60M–
Q4 FY2021Dec 31, 2021-$8.04M–
Q3 FY2021Sep 30, 2021-$38.22M–
Q2 FY2021Jun 30, 2021-$37.64M–
Q1 FY2021Mar 31, 2021-$1.17M–
Q2 FY2020Jun 30, 2020-$42.44M–

More LifeStance Health figures

See a number that looks wrong?